Skip to main content
Top
Published in: Clinical Rheumatology 2/2021

01-02-2021 | Colchicine | Case Based Review

Kidney transplantation as a treatment of choice for AA amyloidosis due to periodic fever syndrome

Authors: K. Graňák, M. Jeseňák, Matej Vnučák, P. Skálová, Ľ. Laca, M. Mokáň, I. Dedinská

Published in: Clinical Rheumatology | Issue 2/2021

Login to get access

Abstract

Renal AA amyloidosis is the most serious complication of periodic fever syndrome, which, inadequate suppression, due to persistent inflammation, leads to nephrotic syndrome and renal failure over several years. In most cases, periodic fever syndromes begin to manifest clinically in early childhood. Occurrence in adulthood is considered rare and is associated with a poorer clinical course. Kidney transplantation (KT) is an effective and safe treatment for end-stage chronic kidney disease (CKD) based on AA amyloidosis. In this paper, we present cases of two patients after deceased donor KT, who have been diagnosed with adult periodic fever syndrome. In the first one, diagnosis and treatment began in advanced stage of CKD and therefore underwent KT with compensated disease, while in the second patient, the disease manifested and diagnosed in the post-KT period. Timely initiation of treatment ensured protection of the graft from amyloid deposition.
Literature
1.
go back to reference Lane T et al (2013) AA amyloidosis complicating the hereditary periodic fever syndromes. Arthritis Rheum 65(4):1116–1121CrossRef Lane T et al (2013) AA amyloidosis complicating the hereditary periodic fever syndromes. Arthritis Rheum 65(4):1116–1121CrossRef
3.
go back to reference Sag E, Bilginer Y, Ozen S (2017) Autoinflammatory diseases with periodic fevers. Curr Rheumatol Rep 19(7):41CrossRef Sag E, Bilginer Y, Ozen S (2017) Autoinflammatory diseases with periodic fevers. Curr Rheumatol Rep 19(7):41CrossRef
4.
go back to reference Messina M, Daidola G, Restagno G, Lavacca A, Ranghino A, Biancone L, Segoloni GP (2013) A case report of AA amyloidosis associated with familial periodic fever syndrome diagnosed after kidney transplantation: never say never. Transplant Proc 45(7):2778–2781CrossRef Messina M, Daidola G, Restagno G, Lavacca A, Ranghino A, Biancone L, Segoloni GP (2013) A case report of AA amyloidosis associated with familial periodic fever syndrome diagnosed after kidney transplantation: never say never. Transplant Proc 45(7):2778–2781CrossRef
5.
go back to reference Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalçinkaya F, Özen S, Majeed H, Ozdogan H, Kastner D, Booth D, Ben-Chetrit E, Pugnère D, Michelon C, Séguret F, Gershoni-Baruch R, International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean Fever (2007) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 56:1706–1712CrossRef Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalçinkaya F, Özen S, Majeed H, Ozdogan H, Kastner D, Booth D, Ben-Chetrit E, Pugnère D, Michelon C, Séguret F, Gershoni-Baruch R, International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean Fever (2007) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 56:1706–1712CrossRef
6.
go back to reference Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRef Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRef
7.
go back to reference Kasifoglu T et al (2013) Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology (Oxford) 53(4):741–745 Kasifoglu T et al (2013) Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology (Oxford) 53(4):741–745
8.
go back to reference Bolaños L et al (2013) Thyroid and renal amyloidosis secondary to cryopyrin associated periodic syndrome (Muckle-Wells syndrome) (mutation NLRP3). Nefrologia 33(2):266–271PubMed Bolaños L et al (2013) Thyroid and renal amyloidosis secondary to cryopyrin associated periodic syndrome (Muckle-Wells syndrome) (mutation NLRP3). Nefrologia 33(2):266–271PubMed
9.
go back to reference Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L, Frenkel J, Anton J, Kone-Paut I, Cattalini M, Bader-Meunier B, Insalaco A, Hentgen V, Merino R, Modesto C, Toplak N, Berendes R, Ozen S, Cimaz R, Jansson A, Brogan PA, Hawkins PN, Ruperto N, Martini A, Woo P, Gattorno M, Paediatric Rheumatology International Trials Organisation (PRINTO), the EUROTRAPS and the Eurofever Project (2014) The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis 73(12):2160–2167CrossRef Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L, Frenkel J, Anton J, Kone-Paut I, Cattalini M, Bader-Meunier B, Insalaco A, Hentgen V, Merino R, Modesto C, Toplak N, Berendes R, Ozen S, Cimaz R, Jansson A, Brogan PA, Hawkins PN, Ruperto N, Martini A, Woo P, Gattorno M, Paediatric Rheumatology International Trials Organisation (PRINTO), the EUROTRAPS and the Eurofever Project (2014) The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis 73(12):2160–2167CrossRef
10.
go back to reference Kofman T, Grimbert P, Canouï-Poitrine F, Zuber J, Garrigue V, Mousson C, Frimat L, Kamar N, Couvrat G, Bouvier N, Albano L, le Thuaut A, Pillebout E, Choukroun G, Couzi L, Peltier J, Mariat C, Delahousse M, Buchler M, le Pogamp P, Bridoux F, Pouteil-Noble C, Lang P, Audard V (2011) Renal transplantation in patients with aa amyloidosis nephropathy: results from a french multicenter study. Am J Transplant 11(11):2423–2431CrossRef Kofman T, Grimbert P, Canouï-Poitrine F, Zuber J, Garrigue V, Mousson C, Frimat L, Kamar N, Couvrat G, Bouvier N, Albano L, le Thuaut A, Pillebout E, Choukroun G, Couzi L, Peltier J, Mariat C, Delahousse M, Buchler M, le Pogamp P, Bridoux F, Pouteil-Noble C, Lang P, Audard V (2011) Renal transplantation in patients with aa amyloidosis nephropathy: results from a french multicenter study. Am J Transplant 11(11):2423–2431CrossRef
11.
go back to reference Sendogan DO, Saritas H, Kumru G, Eyupoglu S, Sadioglu RE, Tuzuner A, Sengul S, Keven K (2019) Outcomes of canakinumab treatment in recipients of kidney transplant with familial mediterranean fever: a case series. Transplant Proc 51(7):2292–2294CrossRef Sendogan DO, Saritas H, Kumru G, Eyupoglu S, Sadioglu RE, Tuzuner A, Sengul S, Keven K (2019) Outcomes of canakinumab treatment in recipients of kidney transplant with familial mediterranean fever: a case series. Transplant Proc 51(7):2292–2294CrossRef
12.
go back to reference Trabulus S, Korkmaz M, Kaya E, Seyahi N (2018) Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever. Clin Transpl 32(8):e13345CrossRef Trabulus S, Korkmaz M, Kaya E, Seyahi N (2018) Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever. Clin Transpl 32(8):e13345CrossRef
13.
go back to reference Ahmadinejad Z, Mansori S, Ziaee V, Alijani N, Aghighi Y, Parvaneh N, Mordinejad MH (2014) Periodic fever: a review on clinical, management and guideline for Iranian patients—part I. Iran J Pediatr 24(1):1–13PubMed Ahmadinejad Z, Mansori S, Ziaee V, Alijani N, Aghighi Y, Parvaneh N, Mordinejad MH (2014) Periodic fever: a review on clinical, management and guideline for Iranian patients—part I. Iran J Pediatr 24(1):1–13PubMed
14.
go back to reference Ahmadinejad Z et al (2014) Periodic fever: a review on clinical, management and guideline for Iranian patients - part II. Iran J Pediatr 24(3):209–240 Ahmadinejad Z et al (2014) Periodic fever: a review on clinical, management and guideline for Iranian patients - part II. Iran J Pediatr 24(3):209–240
Metadata
Title
Kidney transplantation as a treatment of choice for AA amyloidosis due to periodic fever syndrome
Authors
K. Graňák
M. Jeseňák
Matej Vnučák
P. Skálová
Ľ. Laca
M. Mokáň
I. Dedinská
Publication date
01-02-2021

Other articles of this Issue 2/2021

Clinical Rheumatology 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.